###### Strengths and limitations of this study

-   The present study was the first to explore risk factors for ovarian pregnancy (OP).

-   This study initially compared clinical manifestations between OP and tubal pregnancy (TP) patients.

-   We chose TP and IUP women as controls to thoroughly explore the risk factors for OP.

-   As a hospital based case--control study, selection bias was inevitable.

-   There were a limited number of OP patients in this study due to the low incidence of the disease.

Introduction {#s1}
============

Primary ovarian pregnancy (OP), where the gestational sac is implanted in the ovary, is one of the rarest forms of ectopic pregnancy. Its incidence after natural conception ranges from 1/2000 to 1/60 000 deliveries, accounting for 3% of all ectopic pregnancies.[@R1] [@R2] Since the first case was reported in 1682, OP has become an important concern in the field of obstetrics and its incidence is reportedly increasing.[@R3] [@R4]

It is difficult to diagnose OP and differentiate it from haemorrhagic ovarian cyst and tubal pregnancy (TP) before operation. Because of the increased vascularity of ovarian tissue, OP usually results in rupture and haemoperitoneum, making it a life-threatening gynaecological emergency. Therefore, counselling of high-risk patients before conception and better understanding of the risk factors can aid in the rapid diagnosis of OP and improve prognosis. However, the risk factors for OP are poorly studied. Seinera *et al*[@R1] speculated that the risk factors for OP differed from the traditional risk factors for TP. In contrast, some researchers believe that increased OP risk may be associated with factors such as endometriosis, previous adnexal surgeries, previous infectious diseases, history of infertility, in vitro fertilisation and embryo transfer (IVF-ET), polycystic ovarian syndrome and intrauterine device (IUD) use.[@R2] [@R5] Whether these factors play aetiological roles in the increasing occurrence of OP remains debated, and the exact risk factors for OP remain to be ascertained.

To the best of our knowledge, the present study is the first to examine risk factors associated with OP and to compare clinical manifestations between OP and TP patients.

Methods {#s2}
=======

Study design and participants {#s2a}
-----------------------------

This study was conducted between January 2005 and May 2014 at the International Peace Maternity and Child Health Hospital in Shanghai, China. It was approved by the institutional review board of the hospital, and written informed consent was obtained from all participating women. The participants were informed that they had the right to refuse to participate in the study or withdraw from the study at any time and were assured that their information would be kept strictly confidential.

Women who were intraoperatively diagnosed with OP on pathological examination according to the Spiegelberg criteria[@R8] were recruited in the case group (OP group). Two control groups were formed including a TP group and an intrauterine pregnancy (IUP) group. The TP participants were from the in-patient department of the hospital and had a pathological diagnosis of ectopic pregnancy in the fallopian tube. The IUP participants were recruited from the prenatal clinic and family planning clinic of the same hospital, and IUP was confirmed on the basis of ultrasonography and serum β-human chorionic gonadotropin (β-hCG) levels. All three groups were matched in terms of age (±5 years) and gestational age (±7 days), and the number of participants was roughly distributed in a ratio of 1:2:2 in the OP (n=77), TP (n=155) and IUP (n=156) groups.

Data collection and patient examination {#s2b}
---------------------------------------

Data on sociodemographic characteristics (including age (four categories: ≤24, 25--29, 30--35 and ≥35 years), marital status (unmarried or married), education (four categories: primary school or lower, middle school, high school, or collage or above), occupation (three categories: employed, self-employed, or unemployed), personal annual income (three categories: \<¥50 000, ¥50 000--100 000, or \>¥100 000), and smoking (non-smoking or smoker)); reproductive, gynaecological and surgical history (including number of previous abortions (four categories: 0, 1, 2, or ≥3), parity (three categories: 0, 1, or ≥2), history of previous ectopic pregnancy (no or yes), serum *Chlamydia trachomatis* (CT) IgG test (negative or positive), previous infertility (three categories: no, tubal infertility, or other type of infertility), the mode of pregnancy (three categories: natural conception, IVF-ET, or other assisted reproductive technology), a history of caesarean section (no or yes), adnexal surgery (no or yes), and previous appendectomy (no or yes)); and current contraceptive use (six categories: none users, IUD, oral contraceptive pills, female sterilisation, emergency contraceptive pills or other contraceptive methods) were collected via a questionnaire-based interview. For OP and TP patients, the questionnaire also covered some clinical features (findings at the time of presentation at the hospital, eg, abdominal pain, vaginal bleeding and shock).

Five-millilitres of blood samples were collected from each participant after recruitment and tested for serum CT IgG antibody using an ELISA (Beijing Biosynthesis Biotechnology, China). For OP and TP patients, another 5 mLs of blood samples were collected on the day of surgery to test for the serum β-hCG levels. Operation methods used, and the amount of haemoperitoneum detected intraoperatively were also recorded. Serum were used for assay following centrifuging the blood samples, and all assays were conducted within 24 h.

Statistical analysis {#s2c}
--------------------

The χ^2^ test was applied to examine the differences among the three groups. Crude ORs with 95% CIs were calculated for each factor by using univariate logistic regression. Variables found to be associated with OP in the univariate analysis were included in a multivariate logistic regression analysis by forward selection.

To identify differences in clinical features between the OP and TP groups, Student t test was used for continuous variables, while the χ^2^ test was used for categorical variables. Data with Poisson distribution (serum β-hCG level and amount of haemoperitoneum) were later analysed with 10 at the bottom of logarithmic transformation.

Statistical analysis was performed using Statistical Analysis System software (V.8.2; SAS Institute Inc, Cary, North Carolina, USA). p Values were estimated using two-tailed tests, and considered statistically significant if less than 0.05.

Results {#s3}
=======

Univariate analysis {#s3a}
-------------------

The subject recruitment process is shown in [figure 1](#BMJOPEN2014006447F1){ref-type="fig"}. The study finally included 71 women with OP, 145 with TP and 146 with IUP, after 27 participants who refused the interview or provided incomplete information were excluded (7 in the OP group, 10 in the TP group and 10 in the IUP group).

![Recruitment profile of this study.](bmjopen2014006447f01){#BMJOPEN2014006447F1}

The distribution of sociodemographic characteristics among the three groups is listed in [table 1](#BMJOPEN2014006447TB1){ref-type="table"}. No differences were observed in age, marital status, educational attainment, personal annual income and smoking. However, a significant difference was found in occupation (p=0.02).

###### 

Baseline characteristics of enrolled participants

                                       OP   TP        IUP                             
  ------------------------------------ ---- --------- ----- --------- ----- --------- ------
  *Sociodemographic characteristics*                                                  
  Age (years)                                                                         1.00
   ≤24                                 8    (11.43)   16    (11.03)   17    (11.64)   
   25--29                              19   (27.14)   40    (27.59)   37    (25.34)   
   30--34                              32   (45.71)   66    (45.52)   70    (47.95)   
   ≥35                                 11   (15.72)   23    (15.86)   22    (15.07)   
  Marital status                                                                      0.75
   Married                             66   (92.96)   135   (93.10)   139   (95.21)   
   Unmarried                           4    (5.63)    10    (6.90)    7     (4.80)    
  Education                                                                           0.08
   Primary school or lower             11   (15.71)   45    (31.03)   25    (17.12)   
   Middle school                       5    (7.14)    14    (9.66)    13    (8.90)    
   High school                         9    (12.00)   16    (11.03)   18    (12.33)   
   College or above                    45   (64.29)   70    (48.27)   90    (61.64)   
  Occupation                                                                          0.02
   Employed                            61   (87.14)   101   (69.66)   122   (83.56)   
   Self-employed                       2    (2.86)    18    (12.41)   10    (6.85)    
   Unemployed                          7    (10.00)   26    (17.93)   14    (9.59)    
  Personal annual income (RMB)                                                        0.04
   \<50 000                            23   (37.10)   57    (39.31)   65    (44.52)   
   50 000--100 000                     26   (41.94)   43    (29.66)   57    (39.04)   
   \>100 000                           13   (20.97)   45    (31.03)   24    (16.44)   
  Smoking                                                                             0.76
   Non-smoking                         68   (97.14)   138   (95.17)   134   (95.04)   
   Smokers                             2    (2.86)    7     (4.83)    7     (4.97)    

\*The sum does not equal the sample size for all variables because of missing data.

IUP, intrauterine pregnancy; RMB, ren min bi; OP, ovarian pregnancy; TP, tubal pregnancy.

[Table 2](#BMJOPEN2014006447TB2){ref-type="table"} shows the association between OP risk and the participants' reproductive, gynaecological and surgical history, and current contraceptive use. In women who had no abortions previously, the OR of OP among women who had two abortions was lower than in those who had not (OR~1~ 0.37, 95% CI 0.16 to 0.90). In addition, when using TP women as controls, the ORs of OP were significantly lower in women who had a history of ectopic pregnancy (OR~1~ 0.24, 95% CI 0.07 to 0.82), a positive reaction to the CT IgG antibody (OR~1~ 0.34, 95% CI 0.16 to 0.72) and a history of previous adnexal surgery (OR~1~ 0.28, 95% CI 0.11 to 0.71). However, when using IUP women as controls, the OR of OP was higher in women with tubal infertility than in those without (OR~1~ 4.48, 95% CI 1.44 to 13.98). The OR of OP among current IUD users was significantly higher than non-users of any contraceptives (OR~2~ 8.42, 95% CI 1.68 to 42.20).

###### 

Reproductive, gynaecological and surgical history of all enrolled participants

                                     OP   TP        IUP   Crude OR~1~ (95% CI)\*   Crude OR~2~ (95% CI)†                                                           
  ---------------------------------- ---- --------- ----- ------------------------ ----------------------- --------- ---------------------- ---------------------- --------
  *Reproductive history*                                                                                                                                           
  Number of previous abortions                                                                                                                                     0.29
   0                                 37   (52.86)   52    (36.88)                  64                      (43.84)   Ref                    Ref                    
   1                                 22   (31.43)   47    (33.33)                  41                      (28.08)   0.85 (0.43 to 1.67)    0.89 (0.46 to 1.72)    
   2                                 8    (11.43)   31    (21.99)                  26                      (17.81)   0.37 (0.16 to 0.90)    0.53 (0.22 to 1.30)    
   ≥3                                3    (4.29)    11    (7.80)                   15                      (10.27)   0.33 (0.09 to 1.23)    0.35 (0.09 to 1.27)    
  Parity                                                                                                                                                           0.28
   0                                 43   (61.43)   64    (45.39)                  68                      (46.58)   Ref                    Ref                    
   1                                 26   (37.14)   69    (48.94)                  71                      (48.63)   0.62 (0.34 to 1.12)    0.59 (0.33 to 1.07)    
   ≥2                                1    (1.43)    8     (5.67)                   7                       (4.80)    0.20 (0.02 to 1.65)    0.23 (0.03 to 1.95)    
  *Gynaecological history*                                                                                                                                         
  Previous ectopic pregnancy                                                                                                                                       \<0.01
   No                                68   (95.78)   122   (84.72)                  144                     (98.63)   Ref                    Ref                    
   Yes                               3    (4.23)    22    (15.28)                  2                       (1.37)    0.24 (0.07 to 0.82)    3.22 (0.52 to 19.45)   
  Serum CT IgG test                                                                                                                                                \<0.01
   Negative                          57   (85.08)   95    (65.97)                  128                     (90.14)   Ref                    Ref                    
   Positive                          10   (14.93)   49    (34.03)                  14                      (9.86)    0.34 (0.16 to 0.72)    1.60 (0.67 to 3.83)    
  Previous infertility                                                                                                                                             0.002
   No                                55   (84.62)   111   (76.55)                  137                     (94.48)   Ref                    Ref                    
   Others                            1    (1.54)    6     (4.14)                   3                       (2.07)    0.34 (0.04 to 2.86)    0.83 (0.09 to 8.16)    
   Tubal infertility                 9    (13.85)   28    (19.31)                  5                       (3.45)    0.65 (0.29 to 1.47)    4.48 (1.44 to 13.98)   
  Mode of pregnancy                                                                                                                                                0.67
   Natural conception                61   (88.41)   135   (93.10)                  144                     (98.63)   Ref                    Ref                    
   Other ART                         1    (1.45)    3     (2.21)                   2                       (1.37)    0.74 (0.08 to 7.24)    1.18 (0.11 to 13.26)   
   IVF-ET                            7    (10.15)   7     (4.83)                   0                       (0.00)    2.21 (0.74 to 6.59)    NA                     
  Previous caesarean section§                                                                                                                                      0.71
   No                                16   (59.26)   38    (50.00)                  41                      (52.56)   Ref                    Ref                    
   Yes                               11   (40.74)   38    (50.00)                  37                      (47.44)   0.69 (0.28 to 1.67)    0.76 (0.31 to 1.85)    
  Previous adnexal surgery                                                                                                                                         \<0.01
   No                                64   (91.43)   109   (75.17)                  141                     (96.58)   Ref                    Ref                    
   Yes                               6    (8.57)    36    (24.83)                  5                       (3.43)    0.28 (0.11 to 0.71)    2.64 (0.78 to 8.98)    
  Previous appendectomy                                                                                                                                            0.56
   No                                65   (94.20)   138   (97.18)                  140                     (96.55)   Ref                    Ref                    
   Yes                               4    (5.80)    4     (2.82)                   5                       (3.45)    2.12 (0.52 to 8.76)    1.72 (0.45 to 6.63)    
  Current contraceptive experience                                                                                                                                 0.06
   None users                        42   (60.00)   86    (59.31)                  101                     (74.27)   Ref                    Ref                    
   Intrauterine device               7    (10.00)   7     (4.83)                   2                       (1.47)    2.05 (0.67 to 6.22)    8.42 (1.68 to 42.20)   
   Oral contraceptive pills          1    (1.43)    1     (0.69)                   0                       (0.00)    2.05 (0.13 to 33.55)   NA                     
   Female sterilisation              0    (0.00)    2     (1.38)                   0                       (0.00)    NA                     NA                     
   Emergency contraceptive pills     4    (5.71)    25    (17.24)                  8                       (5.88)    0.33 (0.11 to 1.03)    1.20 (0.34 to 4.21)    
   Other contraceptive methods¶      16   (22.86)   24    (16.55)                  35                      (25.74)   1.37 (0.66 to 2.84)    1.10 (0.55 to 2.20)    

\*OR~1~ refers to the OR for OP when using TP patients as control.

†OR~2~ refers to the OR for OP when using IUP women as control.

‡The sum does not necessarily equal the sample size for all variables because of missing data.

§The number of women who had delivered a child was used as the denominator to calculate the percentage.

¶Other contraceptive methods included condoms, the rhythm method and withdrawal.

CT, *Chlamydia trachomatis*; IUP, intrauterine pregnancy; NA, not applicable; OP, ovarian pregnancy; Ref, reference; TP, tubal pregnancy.

Multivariate analysis {#s3b}
---------------------

Variables from the univariate analyses that were included in the multivariate analysis are listed in [table 3](#BMJOPEN2014006447TB3){ref-type="table"}. The final model included only a positive result in the serum CT IgG test, mode of pregnancy, previous adnexal surgery and current contraceptive use.

###### 

Multivariate logistic regression analysis predicting risk factors for OP

                                           Adjusted OR~1~ (95% CI)\*   
  ---------------------------------------- --------------------------- --------
  Serum *Chlamydia trachomatis* IgG test                               \<0.01
   Negative                                Ref                         
   Positive                                0.17 (0.06 to 0.52)         
  Mode of pregnancy                                                    0.02
   Natural conception                      Ref                         
   Other ART                               NA                          
   IVF-ET                                  12.18 (2.23 to 66.58)       
  Previous adnexal surgery                                             0.04
   No                                      Ref                         
   Yes                                     0.25 (0.07 to 0.95)         
  Current contraceptive experience                                     0.03
   Non-users                               Ref                         
   Intrauterine device                     1.42 (0.39 to 5.18)         
   Oral contraceptive pills                NA                          
   Female sterilisation                    NA                          
   LNG-EC                                  0.24 (0.07 to 0.78)         
   Other contraceptive methods†            0.34 (0.03 to 0.87)         

\*OR~1~ refers to the OR for OP when using TP patients as control. All ORs were adjusted for the other variables included in [table 3](#BMJOPEN2014006447TB3){ref-type="table"}, as well as age and occupation.

†Other contraceptive methods included condoms, the rhythm method and withdrawal.

LNG-EC, levonorgestrel emergency contraceptive; NA, not applicable; OP, ovarian pregnancy; Ref, reference; TP, tubal pregnancy.

Compared to the risk of TP, that of OP was lower in women with serological evidence of previous CT infection (adjusted OR~1~ 0.17, 95% CI 0.06 to 0.52), previous adnexal surgery (adjusted OR~1~ 0.25, 95% CI 0.07 to 0.95) and current use of levonorgestrel emergency contraceptive (LNG-EC; adjusted OR~1~ 0.24, 95% CI 0.07 to 0.78), and other contraceptive methods (adjusted OR~1~ 0.34, 95% CI 0.03 to 0.87). In contrast, women who underwent IVF-ET were at a higher risk of OP (adjusted OR~1~ 12.18, 95% CI 2.23 to 66.58) than those who conceived naturally. Further, the incidence of OP was significantly higher than that of IUP among current users of IUDs than among non-users of any contraceptives (adjusted OR: 9.60, 95% CI 1.76 to 42.20; data not shown in table).

Comparison of clinical features between the OP and TP groups {#s3c}
------------------------------------------------------------

[Table 4](#BMJOPEN2014006447TB4){ref-type="table"} outlines the clinical features of patients in the OP and TP groups. Complaints of abdominal pain at presentation were similar between the groups (p=0.12). However, women with OP were less likely to initially present with vaginal bleeding than those with TP (p=0.02). Moreover, shock (p=0.02), rupture (p\<0.01), haemoperitoneum (p\<0.01) and emergency laparotomy (p\<0.01) were more frequent in the OP group than in the TP group.

###### 

Comparison of clinical features between the OP and TP groups

                                     OP            TP                               
  ---------------------------------- ------------- ------------- -------- --------- --------
  Abdominal pain at presentation                                                    
   Yes                               53            (74.65)       93       (64.14)   0.12
   No                                18            (25.35)       52       (35.86)   
  Vaginal bleeding at presentation                                                  
   Yes                               48            (67.61)       119      (82.07)   0.02
   No                                23            (32.39)       26       (17.93)   
  Rupture                                                                           
   Yes                               40            (56.34)       8        (5.52)    \<0.01
   No                                31            (43.66)       137      (94.48)   
  Shock                                                                             
   Yes                               11            (15.49)       8        (5.52)    0.02
   No                                60            (84.51)       137      (94.48)   
  Emergency laparotomy                                                              
   Yes                               14            (19.72)       6        (4.14)    \<0.01
   No                                57            (80.28)       139      (95.86)   
  Initial β-hCG level (IU/mL)†                                                      
   Mean±SD                           3.446±0.679   3.088±0.632   \<0.01             
  Amount of haemoperitoneum (mL)†                                                   
   Mean±SD                           2.402±0.438   1.875±0.453   \<0.01             

\*The sum does not necessarily equal the sample size for all variables because of missing data.

†As the data were non-normally distributed, they were transformed into a normal distribution later with 10 at the bottom of logarithmic transformation.

hCG, human chorionic gonadotropin; OP, ovarian pregnancy; TP, tubal pregnancy.

Discussion {#s4}
==========

In this study, we explored the risk factors for OP, and found that IVF-ET and IUD use may be closely related to the occurrence of OP. Furthermore, OP patients tend to have higher β-hCG levels than women with IUP, and a poorer clinical outcome than TP patients.

OP is an extremely rare type of ectopic pregnancy, and few studies including a significant number of OP cases have been reported. Two possible mechanisms have been proposed to explain OP. One hypothesis is that fertilisation occurs normally and implantation in the ovary follows reflux of the conceptus from the tube.[@R2] The other suggests that various disturbances in ovum release are responsible for ovarian implantation.[@R9] However, the definite aetiology remains unclear. The unusual site and rarity of OP lead to a more complex clinical course, beginning with the difficulty in making an early and accurate diagnosis, which results in an unpredictable outcome and a life-threatening situation if the ovary ruptures.[@R5] Therefore, the present study on the risk factors of OP may help in successful primary prevention of OP.

We found that IVF-ET treatment was significantly more common in OP patients than in TP patients, suggesting IVF-ET as an OP risk factor. The incidence of OP following IVF-ET has been estimated to be 6% of all ectopic pregnancies,[@R10] which is much higher than the 3% reported following natural conception.[@R2] There could be various explanations for these findings. One is reverse migration of one of the transferred embryos toward the fallopian tube and implantation in the ovary.[@R11] Lesny *et al*[@R12] showed that a difficult ET stimulates junctional zone contractions and that strong endometrial waves in the fundal area of the uterus could move mock embryos into the fallopian tubes. They also noted that manipulation with tissue forceps in order to facilitate ET could affect uterine contractility. Oliveira *et al*[@R13] stated that blastocyst-stage ET may be associated with ectopic implantation of embryos in the ovaries. Further, the high volume and pressure of the culture medium injected into the uterus, the tilt-down position of the patient during ET, or perforation of the uterus during ET could contribute to the development of OP.[@R14] Although all these mechanisms explain how OP occurs after IVF-ET, the mechanism underlying the higher OR of OP than TP in women who underwent IVF-ET remains unclear and requires further study.

IUDs were first reported to be associated with OP in 1976.[@R15] However, studies have reported a wide variation in the proportion of OP using IUDs, ranging from 7.1% to 90%,[@R5] [@R16] and this variation may partly be attributed to the differing prevalence of IUD use in the general population. In the present study, 10% (7/70) patients in the OP group and 1.37% patients (2/146) in the IUP group were current users of IUDs, indicating that women using IUDs are more likely to have OP than IUP. This finding might be associated with the fact that IUDs reduce intrauterine implantation but do not have the same protective effect against OP. As Lehfeldt *et al* reported, IUD reduced intrauterine implantation by 99.5%, and tubal implantation by 95%, but have little protective effect against OP.[@R19] Furthermore, another 12-year experience on 19 cases of OP also noted that an IUD was present in 13 of 19 (68%) of the patients.[@R5] Some researchers have speculated that the presence of an IUD in situ may increase host susceptibility to infection, thus increasing the incidence of pelvic inflammatory disease (PID) and the associated sequelae.[@R20] On the one hand, OP might occur after PID because of the deciliation of the endosalpinx and ovum transport delay caused by PID.[@R21] This finding confirms the aetiological role of IUD in OP as well as suggests that tubal factors may be involved in OP. On the other hand, PID can change the ovarian surface and cause defective ovum release, which can lead to intrafollicular fertilisation.

The present study found that a positive reaction to the CT IgG antibody did not show a stronger association with OP than TP. CT is the most common sexually transmitted infection.[@R22] It is commonly asymptomatic, thus leaving women susceptible to infection, leading to colonisation including in the fallopian tube and maintaining an ongoing reservoir for infection.[@R23] Ault *et al*[@R24] showed that a lower genital tract CT infection could spread to the upper reproductive tract and result in salpingitis with a local inflammatory response, which could lead to a predisposition to tubal implantation. Data from a comparative analysis with a large population of infertile women showed that *Chlamydia* antibody titres can predict tubal damage and are quantitatively related to the severity of damage.[@R25] Further, current knowledge suggests that CT infection induces an inflammatory response that eventually leads to tubal epithelial destruction and functional impairment, caused by a high nitric oxide (NO) output mediated by inducible NO synthases.[@R26] CT can lead to ectopic pregnancy by causing tubal abnormalities and dysfunction (eg, abnormal cilia activity or tubal contractility), which is the main reason for TP,[@R27] whereas the tubal factor does not seem to be a crucial factor for OP.[@R28] Therefore, it was not surprising that CT was associated more strongly with TP than with OP. These findings also explained why previous adnexal surgery was not a risk factor for OP but was for TP.

LNG, a synthetic progestogen, is a widely used EC.[@R29] Research has suggested that it acts by delaying the luteinising hormone surge and interfering with ovulation,[@R30] thereby preventing pregnancy. However, several cases of ectopic pregnancy following LNG-EC failure have been reported.[@R31] [@R32] In the present study, 4 OPs, 25 TPs and 8 IUPs were observed among 37 women with LNG-EC failure. Compared with non-users of contraceptives, women who used LNG-EC did not show an increased risk of OP compared to TP. This finding may be associated with the fact that an elevated progesterone concentration could theoretically impair cilia motility in the fallopian tube and lead to a predisposition to tubal implantation in women using progestin-only pills.[@R33] An important part of this study was that clinical features were compared between OP and TP, which, to the best of our knowledge, has not been done previously. We found a significant difference between these groups with respect to vaginal bleeding. OP patients were less likely to present vaginal bleeding than TP patients. This finding may be associated with the fact that because of the increased vascularity of ovarian tissue in OP patients, the endometrium is well maintained with high β-hCG levels in these patients, unlike in the case of TP patients. Many patients consider bleeding the principal sign of an abnormal pregnancy and it is often their strongest motivation to seek medical attention. Without bleeding, patients may be reassured by amenorrhoea as a sign of a normal IUP,[@R34] which might delay the diagnosis and treatment of OP. Therefore, even in patients who do not present with vaginal bleeding, strong suspicion of pregnancy is prudent in order to avoid missing a case of OP.

Our study clearly found higher β-hCG levels on the day of surgery in OP patients than those in TP patients. This may be attributed to the proper embryonic development resulting from the increased vascularity of ovarian tissue in the former. The incidence of rupture was significantly higher in the OP group (56.34%) than the TP group (5.52%). Some researchers have speculated that a high β-hCG level was often related to the rupture in ectopic pregnancy,[@R35] thus, from our findings, we hypothesised that high β-hCG levels are associated with ovary rupture and predict a poor prognosis in OP patients.

Interestingly, this study found a higher incidence of emergency laparotomy and shock in OP patients than in TP patients. Further, the incidence of haemoperitoneum during the operation was significantly higher in the OP group than in the TP group. These findings collectively indicate that OP patients tend to have a poorer prognosis than TP patients.

Although our data is interesting and initially provide information focused on the aetiological research of OP, the recognised drawbacks of retrospective, hospital-based case--control studies must be acknowledged, and the quality of the outcome data may also be biased due to recall bias and selection bias. Another important limitation of the study was the limited sample size due to the extremely low incidence of OP. In this study, there were also a small number of OP patients who underwent IVF-ET, thus, despite the fact that IVF-ET appeared to be a high risk for OP, the CI was relative wide. Therefore, sample size should be enlarged and a prospective cohort study should be further designed to validate the results of this study.

Conclusion {#s5}
==========

Our findings indicated that IVF-ET and current IUD use are risk factors of OP, while previous adnexal surgery, a positive reaction to CT IgG antibody, and LNG-EC use are not associated more strongly with OP than TP. OP patients are more likely to have high β-hCG levels, accompanied by worse clinical outcomes (shock, rupture, haemoperitoneum and need for emergency laparotomy). These risk factors and clinical features seem to have a high predictive value and may aid in early detection of OP, thereby enabling conservative treatment, reduced mortality and morbidity rates, preservation of fertility and lower overall costs of healthcare for OP.
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